RNA-based vaccine candidate against SARS-CoV-2 variants
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RNA-based vaccine candidate against SARS-CoV-2 variants, covering 2024-11-22 to 2024-11-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants [Phase 2]